Cormedix Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cormedix Inc. on April 24, 2012, reporting an event that occurred on April 20, 2012. The Company is a Delaware corporation headquartered in Bridgewater, NJ.
Key Financial Metrics
The filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. However, it explicitly states that the Company has sustained losses so substantial in relation to its operations or financial resources that its ability to continue operations and meet obligations is questionable.
Material Changes and Listing Status
On April 20, 2012, Cormedix received notice from NYSE Amex LLC of non-compliance with Section 1003(a)(iv) of the NYSE Amex Company Guide. This standard addresses financial condition and the ability to continue operations. The notice indicates the Company's financial condition is impaired due to substantial losses.
Outlook, Risks, and Contingencies
- Compliance Plan Deadline: The Company must submit a plan to NYSE Amex by May 21, 2012, detailing actions to regain compliance by August 22, 2012.
- Plan Requirements: The plan must include specific milestones, quarterly financial projections, and details on strategic initiatives.
- Delisting Risk: If the plan is not submitted, not accepted, or if the Company fails to regain compliance by August 22, 2012, NYSE Amex may initiate delisting proceedings.
- Appeal Rights: The Company retains the right to appeal a staff determination to initiate delisting proceedings.
- Uncertainty: There is no assurance that the plan will be accepted or that the Company will make progress consistent with the plan.
Investor Verification Checklist
- Verify the submission status and content of the compliance plan due to NYSE Amex by May 21, 2012.
- Monitor the Company's ability to meet the August 22, 2012 compliance deadline to avoid delisting.
- Review the Company's most recent audited financial statements to quantify the "substantial losses" cited by the exchange.
- Assess the Company's current cash runway and ability to fund operations without additional capital raises.
- Check for any subsequent filings regarding the acceptance or rejection of the compliance plan by NYSE Amex.